Compare
INNOVATE Corp. vs Arcosa, Inc. vs Proto Labs Inc vs Valmont Industries Inc
| Latest fiscal year | INNOVATE Corp. VATE | Arcosa, Inc. ACA | Proto Labs Inc PRLB | Valmont Industries Inc VMI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-27 |
| Revenue | $1.25B | $2.88B | $533.13M | $4.10B |
| Revenue growth (YoY) | +12.5% | +12.2% | +6.4% | +0.7% |
| Gross margin | 16.0% | 22.4% | 44.5% | 30.2% |
| Operating margin | 2.3% | 11.9% | 4.7% | 10.1% |
| Net margin | -4.9% | 7.2% | 4.0% | 8.6% |
| Net income | -$60.60M | $208.40M | $21.24M | $353.69M |
| EPS (Diluted) | -$4.84 | $4.24 | $0.88 | $16.79 |
| Operating cash flow | $146.60M | $341.10M | $74.50M | $456.48M |
| Free cash flow | $146.10M | $175.50M | $59.66M | $311.45M |
| Cash & equivalents | $112.10M | $214.60M | $110.83M | $187.14M |
| Total assets | $950.10M | $4.99B | $763.41M | $3.37B |
| Total liabilities | $1.17B | $2.34B | $89.48M | $1.73B |
| Shareholders' equity | -$226.20M | $2.64B | $673.93M | $1.63B |
| Return on year-end equity | n/a | 7.9% | 3.2% | 21.7% |
| Shares outstanding | 13.66M | 49.00M | 23.63M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | INNOVATE Corp. | Arcosa, Inc. | Proto Labs Inc | Valmont Industries Inc |
|---|---|---|---|---|
| Latest | $1.25B Ended 2025-12-31 | $2.88B Ended 2025-12-31 | $533.13M Ended 2025-12-31 | $4.10B Ended 2025-12-27 |
| 1 year earlier | $1.11B Ended 2024-12-31 | $2.57B Ended 2024-12-31 | $500.89M Ended 2024-12-31 | $4.08B Ended 2024-12-28 |
| 2 years earlier | $1.42B Ended 2023-12-31 | $2.31B Ended 2023-12-31 | $503.88M Ended 2023-12-31 | $4.17B Ended 2023-12-30 |
| 3 years earlier | $1.64B Ended 2022-12-31 | $2.24B Ended 2022-12-31 | $488.40M Ended 2022-12-31 | $4.35B Ended 2022-12-31 |
| 4 years earlier | $1.21B Ended 2021-12-31 | $2.04B Ended 2021-12-31 | $488.10M Ended 2021-12-31 | $3.50B Ended 2021-12-25 |